Delivery Order SPE2DB22D2108-SPE2DB25FU3FX
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,476.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN 80 MG TABLET 30S, a pharmaceutical product, with a completion date of February 3, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.82 firm fixed-price delivery order is for the supply of 4566680655 - TELMISARTAN 80 MG TABLET 30S, with a performance period ending on December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,424.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, is for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. This contract does not have a set-aside designation, indicating open...
This federal contract award, valued at $1,702.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of December 12, 2023. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $4,758.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of February 28, 2025. The contract covers the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.30 Delivery Order contract is for the supply of 4560664400 TELMISARTAN 80 MG TABLET 30S. The contract has an ultimate completion date of April 21, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating...
This federal contract award, valued at $1,470.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support federal healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,004.26 firm-fixed-price delivery order is for the supply of 4563134465 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of December 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,117.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,013,582 units of telmisartan 80 mg tablets in 30-count packages. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award, valued at $7,557.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...